Andrew Dudum is Chief Executive Officer of Hims & Hers Health, Inc.. Currently has a direct ownership of 95,105 shares of HIMS, which is worth approximately $5.69 Million. The most recent transaction as insider was on Jan 26, 2024, when has been sold 52,940 shares (Class A Common Stock) at a price of $9.11 per share, resulting in proceeds of $482,283. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 95.1K
0.22% 3M change
20.0% 12M change
Total Value Held $5.69 Million

Andrew Dudum Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 26 2024
SELL
Open market or private sale
$482,283 $9.11 p/Share
52,940 Reduced 50.62%
51,653 Class A Common Stock
Jan 26 2024
BUY
Exercise of conversion of derivative security
$128,644 $2.43 p/Share
52,940 Added 33.61%
104,593 Class A Common Stock
Jan 25 2024
SELL
Open market or private sale
$1,159,407 $9.08 p/Share
127,688 Reduced 71.2%
51,653 Class A Common Stock
Jan 25 2024
BUY
Exercise of conversion of derivative security
$310,281 $2.43 p/Share
127,688 Added 41.59%
179,341 Class A Common Stock
Dec 29 2023
SELL
Open market or private sale
$194,173 $9.06 p/Share
21,432 Reduced 29.32%
51,653 Class A Common Stock
Dec 29 2023
BUY
Exercise of conversion of derivative security
$52,079 $2.43 p/Share
21,432 Added 22.68%
73,085 Class A Common Stock
Dec 28 2023
SELL
Open market or private sale
$232,007 $9.01 p/Share
25,750 Reduced 33.27%
51,653 Class A Common Stock
Dec 28 2023
BUY
Exercise of conversion of derivative security
$62,572 $2.43 p/Share
25,750 Added 24.96%
77,403 Class A Common Stock
Dec 27 2023
SELL
Open market or private sale
$69,454 $9.02 p/Share
7,700 Reduced 12.97%
51,653 Class A Common Stock
Dec 27 2023
BUY
Exercise of conversion of derivative security
$18,711 $2.43 p/Share
7,700 Added 11.48%
59,353 Class A Common Stock
Dec 15 2023
SELL
Payment of exercise price or tax liability
$509,070 $8.45 p/Share
60,245 Reduced 53.84%
51,653 Class A Common Stock
Dec 15 2023
BUY
Exercise of conversion of derivative security
-
111,898 Added 50.0%
111,898 Class A Common Stock
Dec 01 2023
SELL
Open market or private sale
$219,428 $9.03 p/Share
24,300 Reduced 100.0%
0 Class A Common Stock
Dec 01 2023
BUY
Exercise of conversion of derivative security
$59,049 $2.43 p/Share
24,300 Added 50.0%
24,300 Class A Common Stock
Nov 30 2023
SELL
Open market or private sale
$34,238 $9.01 p/Share
3,800 Reduced 100.0%
0 Class A Common Stock
Nov 30 2023
BUY
Exercise of conversion of derivative security
$9,234 $2.43 p/Share
3,800 Added 50.0%
3,800 Class A Common Stock
Sep 15 2023
SELL
Payment of exercise price or tax liability
$379,824 $6.31 p/Share
60,194 Reduced 53.79%
51,706 Class A Common Stock
Sep 15 2023
BUY
Exercise of conversion of derivative security
-
111,900 Added 50.0%
111,900 Class A Common Stock
Aug 08 2023
SELL
Open market or private sale
$62,375 $9.04 p/Share
6,900 Reduced 100.0%
0 Class A Common Stock
Aug 08 2023
BUY
Exercise of conversion of derivative security
$16,767 $2.43 p/Share
6,900 Added 50.0%
6,900 Class A Common Stock
Jul 19 2023
SELL
Open market or private sale
$215,628 $9.06 p/Share
23,800 Reduced 100.0%
0 Class A Common Stock
Jul 19 2023
BUY
Exercise of conversion of derivative security
$57,834 $2.43 p/Share
23,800 Added 50.0%
23,800 Class A Common Stock
Jul 18 2023
SELL
Open market or private sale
$588,601 $9.13 p/Share
64,469 Reduced 100.0%
0 Class A Common Stock
Jul 18 2023
BUY
Exercise of conversion of derivative security
$156,659 $2.43 p/Share
64,469 Added 50.0%
64,469 Class A Common Stock
Jun 29 2023
SELL
Open market or private sale
$210,003 $9.02 p/Share
23,282 Reduced 100.0%
0 Class A Common Stock
AD

Andrew Dudum

Chief Executive Officer
San Francisco, CA

Track Institutional and Insider Activities on HIMS

Follow Hims & Hers Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HIMS shares.

Notify only if

Insider Trading

Get notified when an Hims & Hers Health, Inc. insider buys or sells HIMS shares.

Notify only if

News

Receive news related to Hims & Hers Health, Inc.

Track Activities on HIMS